Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Pulmonx
(NASDAQ:LUNG)
Intraday
$7.28
-0.02
[-0.27%]
After-Hours
$7.28
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$7.28
-0.02
[-0.27%]
At close: Apr 26
$7.28
0
[0.00%]
After Hours: 4:20PM EDT
Get Report
Watch
Q1 2024 Earnings in 5 days from now on Wed May 1st, after the market close
Conference call scheduled in 5 days at 16:30 PM
Click to view the webcast
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Pulmonx Stock (NASDAQ:LUNG)
Pulmonx Stock (NASDAQ: LUNG)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, April 03, 2024
Navigating 6 Analyst Ratings For Pulmonx
Benzinga Insights
-
Apr 3, 2024, 2:00PM
Piper Sandler Reiterates Overweight on Pulmonx, Maintains $17 Price Target
Benzinga Newsdesk
-
Apr 3, 2024, 12:05PM
Tuesday, April 02, 2024
Pulmonx Announces Appointment Of Mehul Joshi As Chief Financial Officer, Effective April 3, 2024
Benzinga Newsdesk
-
Apr 2, 2024, 4:09PM
Monday, February 26, 2024
Pulmonx Announces Treatment Of The First Patient With The AeriSeal System In CONVERT II Pivotal Trial
Benzinga Newsdesk
-
Feb 26, 2024, 8:02AM
Friday, February 23, 2024
Analyst Ratings For Pulmonx
Benzinga Insights
-
Feb 23, 2024, 7:00AM
Thursday, February 22, 2024
Why Etsy Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
-
Feb 22, 2024, 1:37PM
Pulmonx shares are trading lower after the company reported Q4 financial results.
Benzinga Newsdesk
-
Feb 22, 2024, 10:56AM
Wednesday, February 21, 2024
Pulmonx Q4 2023 GAAP EPS $(0.36) Beats $(0.42) Estimate, Sales $19.28M Beat $18.27M Estimate
Benzinga Newsdesk
-
Feb 21, 2024, 4:54PM
Pulmonx Announces Retirement Of CEO Glen French And Appointment Of Steve Williamson As President And CEO
Benzinga Newsdesk
-
Feb 21, 2024, 4:45PM
Earnings Scheduled For February 21, 2024
Benzinga Insights
-
Feb 21, 2024, 5:09AM
Tuesday, October 31, 2023
Piper Sandler Maintains Overweight on Pulmonx, Lowers Price Target to $13
Benzinga Newsdesk
-
Oct 31, 2023, 3:40PM
Canaccord Genuity Maintains Buy on Pulmonx, Lowers Price Target to $12
Benzinga Newsdesk
-
Oct 31, 2023, 2:18PM
Why JetBlue Airways Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
-
Oct 31, 2023, 1:36PM
Arista Networks, JinkoSolar, Repligen, Shutterstock And Other Big Stocks Moving Higher On Tuesday
Lisa Levin
-
Oct 31, 2023, 12:04PM
Pulmonx shares are trading higher after the company reported a year-over-year increase in Q3 EPS results and better-than-expected revenue results. Also, the company raised its FY23 revenue guidance.
Benzinga Newsdesk
-
Oct 31, 2023, 10:58AM
Monday, October 30, 2023
Pulmonx Increases 2023 Revenue Expectation From $64M-$66M To $67M-$68M
Benzinga Newsdesk
-
Oct 30, 2023, 4:57PM
Pulmonx Q3 EPS $(0.39) Vs. $(038) Prior Year, Sales $17.67M Beat $16.39M Estimate
Benzinga Newsdesk
-
Oct 30, 2023, 4:34PM
Earnings Scheduled For October 30, 2023
Benzinga Insights
-
Oct 30, 2023, 6:11AM
Friday, October 27, 2023
Pulmonx Earnings Preview
Benzinga Insights
-
Oct 27, 2023, 2:01PM
Tuesday, October 10, 2023
Pulmonx Says Derrick Sung Steps Down From His Position As CFO To Pursue Another Opportunity; John McKune Named As Interim CFO
Benzinga Newsdesk
-
Oct 10, 2023, 4:10PM
Pulmonx Says Prelim. Unaudited Q3 Revenue Is Expected To Be ~$17.6M Vs $16.31M Est
Bill Haddad
-
Oct 10, 2023, 4:10PM
Tuesday, September 05, 2023
Benzinga's Top Ratings Upgrades, Downgrades For September 5, 2023
Benzinga Insights
-
Sep 5, 2023, 11:00AM
Craig-Hallum Initiates Coverage On Pulmonx with Buy Rating, Announces Price Target of $18
Benzinga Newsdesk
-
Sep 5, 2023, 8:51AM
Thursday, August 03, 2023
Piper Sandler Maintains Overweight on Pulmonx, Raises Price Target to $17
Benzinga Newsdesk
-
Aug 3, 2023, 12:41PM
Wednesday, August 02, 2023
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
-
Aug 2, 2023, 5:32PM
Pulmonx Q2 EPS $(0.43), Inline, Sales $17.19M Beat $15.91M Estimate
Benzinga Newsdesk
-
Aug 2, 2023, 4:41PM
Earnings Scheduled For August 2, 2023
Benzinga Insights
-
Aug 2, 2023, 8:45AM
Tuesday, August 01, 2023
A Preview Of Pulmonx's Earnings
Benzinga Insights
-
Aug 1, 2023, 2:01PM
Wednesday, July 26, 2023
Pulmonx To Present At The Canaccord Genuity 43rd Annual Growth Conference
Benzinga Newsdesk
-
Jul 26, 2023, 5:15PM
Tuesday, July 11, 2023
Citigroup Maintains Buy on Pulmonx, Raises Price Target to $16
Benzinga Newsdesk
-
Jul 11, 2023, 10:29AM
Wednesday, May 03, 2023
Citigroup Maintains Buy on Pulmonx, Raises Price Target to $14
Benzinga Newsdesk
-
May 3, 2023, 12:54PM
7 Analysts Have This to Say About Pulmonx
Benzinga Insights
-
May 3, 2023, 11:01AM
Piper Sandler Maintains Overweight on Pulmonx, Raises Price Target to $15
Benzinga Newsdesk
-
May 3, 2023, 9:25AM
Morgan Stanley Maintains Equal-Weight on Pulmonx, Raises Price Target to $14
Benzinga Newsdesk
-
May 3, 2023, 8:40AM
Tuesday, May 02, 2023
Pulmonx Q1 EPS $(0.42) Beats $(0.44) Estimate, Sales $14.54M Beat $13.49M Estimate
Benzinga Newsdesk
-
May 2, 2023, 4:17PM
Monday, May 01, 2023
A Preview Of Pulmonx's Earnings
Benzinga Insights
-
May 1, 2023, 1:01PM
Monday, April 03, 2023
Analyst Ratings for Pulmonx
Benzinga Insights
-
Apr 3, 2023, 12:01PM
Citigroup Maintains Buy on Pulmonx, Raises Price Target to $13
Benzinga Newsdesk
-
Apr 3, 2023, 7:05AM
Tuesday, February 28, 2023
Top 5 Health Care Stocks That You May Want To Dump In Q1 2023
Lisa Levin
-
Feb 28, 2023, 8:40AM
Monday, February 27, 2023
Benzinga's Top Ratings Upgrades, Downgrades For February 27, 2023
Benzinga Insights
-
Feb 27, 2023, 10:00AM
Wells Fargo Upgrades Pulmonx to Overweight, Raises Price Target to $15
Benzinga Newsdesk
-
Feb 27, 2023, 6:52AM
Friday, February 24, 2023
Where Pulmonx Stands With Analysts
Benzinga Insights
-
Feb 24, 2023, 3:01PM
Citigroup Maintains Buy on Pulmonx, Raises Price Target to $12
Benzinga Newsdesk
-
Feb 24, 2023, 8:38AM
Thursday, February 23, 2023
Pulmonx shares are trading higher after the company reported better-than-expected Q4 EPS and sales results and issued FY23 revenue guidance above estimates.
Benzinga Newsdesk
-
Feb 23, 2023, 2:08PM
Why Domino's Pizza Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
-
Feb 23, 2023, 12:59PM
Comfort Systems, Gannett, CommScope And Other Big Stocks Moving Higher On Thursday
Lisa Levin
-
Feb 23, 2023, 11:15AM
Nasdaq Jumps 100 Points; US GDP Rises 2.7% In Q4
Lisa Levin
-
Feb 23, 2023, 9:51AM
Canaccord Genuity Maintains Buy on Pulmonx, Raises Price Target to $20
Benzinga Newsdesk
-
Feb 23, 2023, 9:46AM
Morgan Stanley Maintains Equal-Weight on Pulmonx, Raises Price Target to $11
Benzinga Newsdesk
-
Feb 23, 2023, 8:33AM
Wednesday, February 22, 2023
Pulmonx Sees FY23 Revenue $63M-$65M Vs $62.1M Est.
Michael Horton
-
Feb 22, 2023, 4:57PM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch